123 related articles for article (PubMed ID: 15696966)
1. Genetic analysis of human glioblastomas using a genomic microarray system.
Suzuki T; Maruno M; Wada K; Kagawa N; Fujimoto Y; Hashimoto N; Izumoto S; Yoshimine T
Brain Tumor Pathol; 2004; 21(1):27-34. PubMed ID: 15696966
[TBL] [Abstract][Full Text] [Related]
2. Detection of gene amplification and deletion in high-grade gliomas using a genome DNA microarray (GenoSensor Array 300).
Sasaki T; Arai H; Beppu T; Ogasawara K
Brain Tumor Pathol; 2003; 20(2):59-63. PubMed ID: 14756442
[TBL] [Abstract][Full Text] [Related]
3. Detrended fluctuation analysis of genome-wide copy number profiles of glioblastomas using array-based comparative genomic hybridization.
Nakahara Y; Shiraishi T; Okamoto H; Mineta T; Oishi T; Sasaki K; Tabuchi K
Neuro Oncol; 2004 Oct; 6(4):281-9. PubMed ID: 15494095
[TBL] [Abstract][Full Text] [Related]
4. A survey of glioblastoma genomic amplifications and deletions.
Rao SK; Edwards J; Joshi AD; Siu IM; Riggins GJ
J Neurooncol; 2010 Jan; 96(2):169-79. PubMed ID: 19609742
[TBL] [Abstract][Full Text] [Related]
5. Detailed characterization of alterations of chromosomes 7, 9, and 10 in glioblastomas as assessed by single-nucleotide polymorphism arrays.
Crespo I; Vital AL; Nieto AB; Rebelo O; Tão H; Lopes MC; Oliveira CR; French PJ; Orfao A; Tabernero MD
J Mol Diagn; 2011 Nov; 13(6):634-47. PubMed ID: 21884817
[TBL] [Abstract][Full Text] [Related]
6. Intratumoral patterns of genomic imbalance in glioblastomas.
Nobusawa S; Lachuer J; Wierinckx A; Kim YH; Huang J; Legras C; Kleihues P; Ohgaki H
Brain Pathol; 2010 Sep; 20(5):936-44. PubMed ID: 20406234
[TBL] [Abstract][Full Text] [Related]
7. Genetic analyses for predictors of radiation response in glioblastoma.
Shih HA; Betensky RA; Dorfman MV; Louis DN; Loeffler JS; Batchelor TT
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):704-10. PubMed ID: 15978739
[TBL] [Abstract][Full Text] [Related]
8. Chromosomal abnormalities in human glioblastomas: gain in chromosome 7p correlating with loss in chromosome 10q.
Inda MM; Fan X; Muñoz J; Perot C; Fauvet D; Danglot G; Palacio A; Madero P; Zazpe I; Portillo E; Tuñón T; Martínez-Peñuela JM; Alfaro J; Eiras J; Bernheim A; Castresana JS
Mol Carcinog; 2003 Jan; 36(1):6-14. PubMed ID: 12503074
[TBL] [Abstract][Full Text] [Related]
9. Identification of novel candidate target genes in amplicons of Glioblastoma multiforme tumors detected by expression and CGH microarray profiling.
Ruano Y; Mollejo M; Ribalta T; Fiaño C; Camacho FI; Gómez E; de Lope AR; Hernández-Moneo JL; Martínez P; Meléndez B
Mol Cancer; 2006 Sep; 5():39. PubMed ID: 17002787
[TBL] [Abstract][Full Text] [Related]
10. Whole-genome analysis of human astrocytic tumors by comparative genomic hybridization.
Maruno M; Ninomiya H; Ghulam Muhammad AK; Hirata M; Kato A; Yoshimine T
Brain Tumor Pathol; 2000; 17(1):21-7. PubMed ID: 10982006
[TBL] [Abstract][Full Text] [Related]
11. Primary glioblastomas with and without EGFR amplification: relationship to genetic alterations and clinicopathological features.
Benito R; Gil-Benso R; Quilis V; Perez M; Gregori-Romero M; Roldan P; Gonzalez-Darder J; Cerdá-Nicolas M; Lopez-Gines C
Neuropathology; 2010 Aug; 30(4):392-400. PubMed ID: 20051017
[TBL] [Abstract][Full Text] [Related]
12. Identification of oligodendroglioma specific chromosomal copy number changes in the glioblastoma MI-4 cell line by array-CGH and FISH analyses.
Magnani I; Moroni RF; Roversi G; Beghini A; Pfundt R; Schoenmakers EF; Larizza L
Cancer Genet Cytogenet; 2005 Sep; 161(2):140-5. PubMed ID: 16102584
[TBL] [Abstract][Full Text] [Related]
13. Pathways leading to glioblastoma multiforme: a molecular analysis of genetic alterations in 65 astrocytic tumors.
Lang FF; Miller DC; Koslow M; Newcomb EW
J Neurosurg; 1994 Sep; 81(3):427-36. PubMed ID: 8057151
[TBL] [Abstract][Full Text] [Related]
14. Molecular genetic correlates of p16, cdk4, and pRb immunohistochemistry in glioblastomas.
Burns KL; Ueki K; Jhung SL; Koh J; Louis DN
J Neuropathol Exp Neurol; 1998 Feb; 57(2):122-30. PubMed ID: 9600204
[TBL] [Abstract][Full Text] [Related]
15. CDKN2A deletion in pediatric versus adult glioblastomas and predictive value of p16 immunohistochemistry.
Purkait S; Jha P; Sharma MC; Suri V; Sharma M; Kale SS; Sarkar C
Neuropathology; 2013 Aug; 33(4):405-12. PubMed ID: 23311918
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive analysis of genomic alterations in gliosarcoma and its two tissue components.
Actor B; Cobbers JM; Büschges R; Wolter M; Knobbe CB; Lichter P; Reifenberger G; Weber RG
Genes Chromosomes Cancer; 2002 Aug; 34(4):416-27. PubMed ID: 12112531
[TBL] [Abstract][Full Text] [Related]
17. Age-dependent prognostic effects of genetic alterations in glioblastoma.
Batchelor TT; Betensky RA; Esposito JM; Pham LD; Dorfman MV; Piscatelli N; Jhung S; Rhee D; Louis DN
Clin Cancer Res; 2004 Jan; 10(1 Pt 1):228-33. PubMed ID: 14734474
[TBL] [Abstract][Full Text] [Related]
18. Mutation of the PTEN (MMAC1) tumor suppressor gene in a subset of glioblastomas but not in meningiomas with loss of chromosome arm 10q.
Boström J; Cobbers JM; Wolter M; Tabatabai G; Weber RG; Lichter P; Collins VP; Reifenberger G
Cancer Res; 1998 Jan; 58(1):29-33. PubMed ID: 9426052
[TBL] [Abstract][Full Text] [Related]
19. Alterations of chromosomal copy number during progression of diffuse-type gastric carcinomas: metaphase- and array-based comparative genomic hybridization analyses of multiple samples from individual tumours.
Peng DF; Sugihara H; Mukaisho K; Tsubosa Y; Hattori T
J Pathol; 2003 Nov; 201(3):439-50. PubMed ID: 14595756
[TBL] [Abstract][Full Text] [Related]
20. Correlation among pathology, genotype, and patient outcomes in glioblastoma.
Homma T; Fukushima T; Vaccarella S; Yonekawa Y; Di Patre PL; Franceschi S; Ohgaki H
J Neuropathol Exp Neurol; 2006 Sep; 65(9):846-54. PubMed ID: 16957578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]